Market revenue in 2022 | USD 22.4 million |
Market revenue in 2030 | USD 31.3 million |
Growth rate | 4.3% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Analyzers |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.63% in 2022. Horizon Databook has segmented the UAE thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE thrombosis & hemostasis biomarkers market growth can be attributed to the availability of major financial resources and adequate government funding. Being a high-income country, the UAE aims to provide universal access to updated & advanced healthcare services.
Initiatives undertaken by the Government of UAE to create awareness among people are further anticipated to propel growth. Growing government investments in the healthcare sector are likely to fuel market growth over the forecast period.
For instance, in 2019, the government allocated a budget of USD 1.2 billion for healthcare, USD 540 million of which was granted for innovations in healthcare. These investments are expected to boost the research related to thrombosis & hemostasis biomarkers, along with the provision of better healthcare access to the population.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into UAE thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account